<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p6" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_6{left:130px;bottom:1195px;letter-spacing:0.21px;}
#t2_6{left:811px;bottom:1195px;}
#t3_6{left:130px;bottom:1108px;letter-spacing:0.14px;}
#t4_6{left:238px;bottom:1109px;letter-spacing:-0.2px;}
#t5_6{left:253px;bottom:1075px;letter-spacing:-0.01px;}
#t6_6{left:253px;bottom:1055px;letter-spacing:-0.01px;}
#t7_6{left:253px;bottom:1036px;letter-spacing:-0.01px;}
#t8_6{left:253px;bottom:1017px;letter-spacing:-0.01px;}
#t9_6{left:253px;bottom:997px;letter-spacing:-0.01px;}
#ta_6{left:253px;bottom:978px;letter-spacing:-0.01px;}
#tb_6{left:253px;bottom:958px;letter-spacing:-0.01px;}
#tc_6{left:253px;bottom:939px;letter-spacing:-0.01px;}
#td_6{left:253px;bottom:884px;letter-spacing:-0.01px;}
#te_6{left:253px;bottom:865px;letter-spacing:-0.01px;}
#tf_6{left:253px;bottom:831px;letter-spacing:-0.01px;}
#tg_6{left:253px;bottom:811px;letter-spacing:-0.01px;}
#th_6{left:253px;bottom:792px;letter-spacing:-0.01px;}
#ti_6{left:253px;bottom:737px;letter-spacing:-0.01px;}
#tj_6{left:253px;bottom:718px;letter-spacing:-0.01px;}
#tk_6{left:253px;bottom:699px;letter-spacing:-0.01px;}
#tl_6{left:253px;bottom:679px;letter-spacing:-0.01px;}
#tm_6{left:253px;bottom:660px;letter-spacing:-0.01px;}
#tn_6{left:130px;bottom:554px;letter-spacing:0.14px;}
#to_6{left:238px;bottom:555px;letter-spacing:0.02px;}
#tp_6{left:238px;bottom:532px;letter-spacing:-0.01px;}
#tq_6{left:238px;bottom:512px;letter-spacing:-0.01px;}
#tr_6{left:238px;bottom:493px;letter-spacing:-0.01px;}
#ts_6{left:238px;bottom:474px;letter-spacing:-0.01px;}
#tt_6{left:238px;bottom:454px;letter-spacing:-0.01px;}
#tu_6{left:238px;bottom:435px;letter-spacing:-0.01px;}
#tv_6{left:566px;bottom:435px;letter-spacing:-0.01px;}
#tw_6{left:238px;bottom:415px;letter-spacing:-0.01px;}
#tx_6{left:238px;bottom:396px;letter-spacing:-0.01px;}
#ty_6{left:238px;bottom:376px;letter-spacing:-0.01px;}
#tz_6{left:238px;bottom:357px;letter-spacing:-0.01px;}
#t10_6{left:238px;bottom:338px;letter-spacing:-0.01px;}
#t11_6{left:238px;bottom:260px;letter-spacing:-0.01px;}
#t12_6{left:238px;bottom:241px;letter-spacing:-0.01px;}
#t13_6{left:238px;bottom:221px;letter-spacing:-0.01px;}
#t14_6{left:238px;bottom:202px;letter-spacing:-0.01px;}
#t15_6{left:238px;bottom:182px;letter-spacing:-0.01px;}
#t16_6{left:238px;bottom:163px;letter-spacing:-0.01px;}
#t17_6{left:238px;bottom:143px;letter-spacing:-0.01px;}
#t18_6{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_6{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_6{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_6{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_6{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_6{font-size:16px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_6{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.s6_6{font-size:11px;font-family:NotoSans-Regular_7j-_1;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts6" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-_1;
	src: url("fonts/NotoSans-Regular_7j-_1.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg6Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg6" style="-webkit-user-select: none;"><object width="908" height="1286" data="6/6.svg" type="image/svg+xml" id="pdf6" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_6" class="t s0_6">1.6. Special note </span><span id="t2_6" class="t s1_6">6 </span>
<span id="t3_6" class="t s2_6">1.6. </span><span id="t4_6" class="t s2_6">Special note </span>
<span id="t5_6" class="t s3_6">Medicine is subject to a continuous development process, so that all information, </span>
<span id="t6_6" class="t s3_6">particularly on diagnostic and therapeutic procedures, can only ever correspond to the </span>
<span id="t7_6" class="t s3_6">state of knowledge at the time the guideline was printed. The greatest possible care was </span>
<span id="t8_6" class="t s3_6">taken with regard to the recommendations given for therapy and the selection and </span>
<span id="t9_6" class="t s3_6">dosage of medication. Nevertheless, users are asked to consult the package inserts and </span>
<span id="ta_6" class="t s3_6">technical information provided by the manufacturers for checking and to consult a </span>
<span id="tb_6" class="t s3_6">specialist in case of doubt. In the general interest, any discrepancies should be reported </span>
<span id="tc_6" class="t s3_6">to the OL editorial team. </span>
<span id="td_6" class="t s3_6">The user remains responsible for any diagnostic and therapeutic application, </span>
<span id="te_6" class="t s3_6">medication and dosage. </span>
<span id="tf_6" class="t s3_6">Registered trademarks (protected trade names) are not specifically identified in this </span>
<span id="tg_6" class="t s3_6">guideline. The absence of such a reference cannot therefore be taken to mean that the </span>
<span id="th_6" class="t s3_6">name in question is a free trade name. </span>
<span id="ti_6" class="t s3_6">The work is protected by copyright in all its parts. Any use outside the provisions of </span>
<span id="tj_6" class="t s3_6">copyright law is prohibited and punishable without the written consent of the OL editorial </span>
<span id="tk_6" class="t s3_6">team. No part of the work may be reproduced in any form without the written consent of </span>
<span id="tl_6" class="t s3_6">the OL editorial team. This applies in particular to reproductions, translations, microfilming </span>
<span id="tm_6" class="t s3_6">and storage, use and exploitation in electronic systems, intranets and the Internet. </span>
<span id="tn_6" class="t s2_6">1.7. </span><span id="to_6" class="t s4_6">Objectives of the Oncology Guideline Programme </span>
<span id="tp_6" class="t s3_6">The Association of Scientific Medical Societies, the German Cancer Society and the German </span>
<span id="tq_6" class="t s3_6">Cancer Aid have set themselves the goal of jointly promoting and supporting the </span>
<span id="tr_6" class="t s3_6">development, updating and use of scientifically based and practicable guidelines in oncology </span>
<span id="ts_6" class="t s3_6">with the Oncology Guidelines Program (OL). The basis of this program is based on the medical </span>
<span id="tt_6" class="t s3_6">and scientific findings of the professional societies and the DKG, the consensus of medical </span>
<span id="tu_6" class="t s3_6">experts, users and patients, as well as on the AWMF's </span><span id="tv_6" class="t s5_6">set of rules for the development of </span>
<span id="tw_6" class="t s5_6">guidelines and the technical support and funding from the German Cancer Aid. In order to </span>
<span id="tx_6" class="t s5_6">reflect the current state of medical knowledge and to take medical progress into account, </span>
<span id="ty_6" class="t s5_6">guidelines must be regularly reviewed and updated. The application of the AWMF set of rules </span>
<span id="tz_6" class="t s5_6">should be the basis for the development of high-quality oncology guidelines. Since guidelines </span>
<span id="t10_6" class="t s5_6">are an important instrument of quality assurance and </span>
<span id="t11_6" class="t s5_6">quality management in oncology, they should be systematically and sustainably integrated </span>
<span id="t12_6" class="t s5_6">into everyday care. Active </span>
<span id="t13_6" class="t s5_6">Implementation measures and evaluation programs are an important part of the promotion of </span>
<span id="t14_6" class="t s5_6">the Oncology Guideline Program. The aim of the program is to create professional and </span>
<span id="t15_6" class="t s5_6">medium-term financially secure conditions for the development and provision of high-quality </span>
<span id="t16_6" class="t s5_6">guidelines in Germany. These high-quality guidelines not only serve the structured transfer of </span>
<span id="t17_6" class="t s5_6">knowledge, but can also be used in the design of the structures of the </span>
<span id="t18_6" class="t s6_6">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
